Boston Scientific "Rainy Day Man" James Taylor Steps In To Head Operations
This article was originally published in The Gray Sheet
Executive Summary
James Taylor's top priorities in assuming the position of senior VP-corporate operations at Boston Scientific are to improve manufacturing quality and drive down operating costs, the company says.
You may also be interested in...
Boston Scientific Sees Return To Double-Digit Growth In Second Half Of 2000
Resumption of Boston Scientific's historic 20%-plus annual sales growth rate will occur the second half of 2000, the company is assuring investors, as key holes in the firm's product pipeline are filled early in the year, including release of advanced coronary stent systems.
Boston Scientific Sees Return To Double-Digit Growth In Second Half Of 2000
Resumption of Boston Scientific's historic 20%-plus annual sales growth rate will occur the second half of 2000, the company is assuring investors, as key holes in the firm's product pipeline are filled early in the year, including release of advanced coronary stent systems.
Boston Scientific Pursues Dual Strategy In Addressing RotaLink Recall
Boston Scientific may opt to restart production of its original Rotablator atherectomy system following the Aug. 6 recall of the next-generation RotaLink Plus, the company reported at a same-day teleconference.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: